T. F. Aiello Et Al. , "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.," Haematologica , 2024
Aiello, T. F. Et Al. 2024. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.. Haematologica .
Aiello, T. F., Salmanton-Garcia, J., Marchesi, F., Weinbergerova, B., Glenthoj, A., Van Praet, J., ... Farina, F.(2024). Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.. Haematologica .
Aiello, Tommaso Et Al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.," Haematologica , 2024
Aiello, Tommaso F. Et Al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.." Haematologica , 2024
Aiello, T. F. Et Al. (2024) . "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.." Haematologica .
@article{article, author={Tommaso Francesco Aiello Et Al. }, title={Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.}, journal={Haematologica}, year=2024}